Intelligence Β· Patent portfolio

Takeda Patents

Full USPTO pharma patent portfolio for Takeda β€” grant dates, expiration, and drug cross-links.

Patents
1,436
Expiring ≀24m
81

Quick answer

Takeda has 1,436 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 81 expire within 24 months β€” use filters for patent-cliff planning.

Page 10 of 30

  1. US 9878989

    Heterocyclic compound

    Expires Mon Jan 25 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  2. US 9868725

    Isoindoline-1-one derivatives as cholinergic muscarinic M1 receptor positive alloesteric modulator activity for the treatment of Alzheimer's disease

    Expires Mon Jan 11 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  3. US 9867876

    Parenteral norovirus vaccine formulations

    Expires Mon Jan 11 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  4. US 9861691

    Norovirus vaccine formulations

    Expires Mon Jan 04 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  5. US 9856310

    UTI fusion proteins

    Expires Mon Dec 28 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  6. US 9834520

    Heterocyclic compound

    Expires Mon Nov 30 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  7. US 9833410

    Lyophilized formulation comprising GM-CSF neutralizing compound

    Expires Mon Nov 30 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  8. US 9834757

    Hand, foot, and mouth vaccines and methods of manufacture and use thereof

    Expires Mon Nov 30 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  9. US 9828357

    Cyclic compounds

    Expires Mon Nov 23 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  10. US 9827255

    Fumagillol derivatives

    Expires Mon Nov 23 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  11. US 9821049

    Method of conferring a protective immune response to Norovirus

    Expires Mon Nov 16 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  12. US 9815938

    Production method for poly(amino acid)

    Expires Mon Nov 09 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  13. US 9814686

    Rolled collagen carrier

    Expires Mon Nov 09 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  14. US 9809569

    Process for producing heterocyclic compound

    Expires Mon Nov 02 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  15. US 9801907

    Film-coated and/or granulated calcium-containing compounds and use therof in pharmaceutical compositions

    Expires Mon Oct 26 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  16. US 9801872

    Pyridinyl and fused pyridinyl triazolone derivatives

    Expires Mon Oct 26 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  17. US 9801934

    Parenteral norovirus vaccine formulations

    Expires Mon Oct 26 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  18. US 9790285

    Anti-CD38 antibodies

    Expires Mon Oct 12 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  19. US 9789084

    Nitrogen-containing heterocyclic compound

    Expires Mon Oct 12 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  20. US 9789083

    Nitrogen-containing heterocyclic compound

    Expires Mon Oct 12 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  21. US 9790201

    Piperidine and azepine derivatives as prokineticin receptor modulators

    Expires Mon Oct 12 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  22. US 9790220

    Substituted cyclopentanes, tetrahydrofuranes and pyrrolidines as orexin receptor antagonists

    Expires Mon Oct 12 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  23. US 9776962

    Aromatic compounds with GPR40 agonistic activity

    Expires Mon Sep 28 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  24. US 9775827

    Nitrogen-containing heterocyclic compound

    Expires Mon Sep 28 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  25. US 9777005

    Bicyclic heterocyclic compound containing a substituted pyrrole ring

    Expires Mon Sep 28 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  26. US 9770450

    4-OXO-3,4-dihydro-1,2,3-benzotriazine as modulators of GPR139

    Expires Mon Sep 21 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  27. US 9770452

    Quinoxaline derivatives as GPR6 modulators

    Expires Mon Sep 21 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  28. US 9757377

    Solid preparation

    Expires Mon Sep 07 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  29. US 9750748

    Pyridazinones as DAAO enzyme inhibitors

    Expires Mon Aug 31 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  30. US 9751878

    Tetrahydronaphthyridine somatostatin receptor 5 antagonists

    Expires Mon Aug 31 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  31. US 9751885

    Cyclopropanamine compound and use thereof

    Expires Mon Aug 31 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  32. US 9745325

    Fused heterocyclic compound

    Expires Mon Aug 24 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  33. US 9724339

    Methods and drug products for treating alzheimer's disease

    Expires Mon Aug 03 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  34. US 9718814

    Cyclopropanamine compound and use thereof

    Expires Mon Jul 27 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  35. US 9713595

    Sustained-release composition and method for producing the same

    Expires Mon Jul 20 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  36. US 9714241

    Cyclopropanamine compound and use thereof

    Expires Mon Jul 20 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  37. US 9713638

    Compositions and methods for rapid immunization against dengue virus

    Expires Mon Jul 20 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  38. US 9708313

    Substituted pyrido[3,4-b]pyrazines as GPR6 modulators

    Expires Mon Jul 13 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  39. US 9708296

    6-(5-hydroxy-1H-pyrazol-1-yl)nicotinamide inhibitors of PHD

    Expires Mon Jul 13 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  40. US 9701623

    Di-aliphatic substituted pegylated lipids

    Expires Mon Jul 06 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  41. US 9695195

    5-HT3 receptor antagonists

    Expires Mon Jun 29 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  42. US 9693962

    Dry-coated tablet

    Expires Mon Jun 29 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  43. US 9682925

    Cyclopropaneamine compound

    Expires Mon Jun 15 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  44. US 9676869

    Conjugated anti-CD38 antibodies

    Expires Mon Jun 08 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  45. US 9675597

    Nitrogen-containing heterocyclic compound

    Expires Mon Jun 08 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  46. US 9670229

    5-HT3 receptor antagonists

    Expires Mon Jun 01 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  47. US 9662316

    Nitrogen-containing heterocyclic compound

    Expires Mon May 25 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  48. US 9663514

    Substituted 6-aza-isoindolin-1-one derivatives

    Expires Mon May 25 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

How many patents does Takeda have?

1,436 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).

When do Takeda patents expire?

81 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.

Where does this data come from?

USPTO PatentsView bulk data filtered to pharmaceutical CPC classes (A61K, A61P), cross-linked to NovaPharmaNews company and drug profiles. See our data sources page for methodology.

Data attribution: Data sources Β· Patent directory